Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LVS vs GSK✓SelectedUSD · GSKLVS vs GSK performance historyLatest closeAs of+2.70%11/13
Stock and ETF performance explorer

LVS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+39.7%
GSK return
+215.4%
Excess return
-175.7%
Maximum drawdown
-99.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+2.7%+0.5%+2.2%+2.4%
7D-0.8%+1.1%-2.0%-1.5%
30D+10.0%+6.3%+3.7%+6.0%
3M-11.0%+1.8%-12.8%-12.3%
6M-20.1%+1.7%-21.8%-21.8%
YTD-36.3%+6.5%-42.9%-40.1%
1Y-36.8%+9.5%-46.3%-41.6%
3Y-9.5%+65.3%-74.8%-38.0%
5Y+9.3%+43.7%-34.4%-21.1%
10Y-11.0%+104.1%-115.1%-52.7%
All+39.7%+215.4%-175.7%-47.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling